Skip to content

GTRDYIJWUWRGOM-GOOPYHEFSA-N

C36H40F2N6O5 — CID 129068123

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl (2S)-4,4-difluoro-2-[6-[2-[4-[2-[(2S)-2-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]ethynyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CC(F)(F)C[C@H]1c1nc2ccc(C#Cc3ccc(-c4cnc([C@@]5(O)CCCN5C(=O)OC(C)(C)C)[nH]4)cc3)cc2[nH]1
InChIInChI=1S/C36H40F2N6O5/c1-33(2,3)48-31(45)43-21-35(37,38)19-28(43)29-40-25-15-12-23(18-26(25)41-29)9-8-22-10-13-24(14-11-22)27-20-39-30(42-27)36(47)16-7-17-44(36)32(46)49-34(4,5)6/h10-15,18,20,28,47H,7,16-17,19,21H2,1-6H3,(H,39,42)(H,40,41)/t28-,36-/m0/s1
InChIKeyGTRDYIJWUWRGOM-GOOPYHEFSA-N
MW674.75 g/mol
LogP6.85
Rot. Bonds3

About GTRDYIJWUWRGOM-GOOPYHEFSA-N

GTRDYIJWUWRGOM-GOOPYHEFSA-N (PubChem CID 129068123) has the molecular formula C36H40F2N6O5 and a molecular weight of 674.75 g/mol. Its IUPAC name is tert-butyl (2S)-4,4-difluoro-2-[6-[2-[4-[2-[(2S)-2-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]ethynyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate.

Molecular Properties

Compound NameGTRDYIJWUWRGOM-GOOPYHEFSA-N
PubChem CID129068123
Molecular FormulaC36H40F2N6O5
Molecular Weight674.75 g/mol
Exact Mass674.30
IUPAC Nametert-butyl (2S)-4,4-difluoro-2-[6-[2-[4-[2-[(2S)-2-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]ethynyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CC(F)(F)C[C@H]1c1nc2ccc(C#Cc3ccc(-c4cnc([C@@]5(O)CCCN5C(=O)OC(C)(C)C)[nH]4)cc3)cc2[nH]1
InChIInChI=1S/C36H40F2N6O5/c1-33(2,3)48-31(45)43-21-35(37,38)19-28(43)29-40-25-15-12-23(18-26(25)41-29)9-8-22-10-13-24(14-11-22)27-20-39-30(42-27)36(47)16-7-17-44(36)32(46)49-34(4,5)6/h10-15,18,20,28,47H,7,16-17,19,21H2,1-6H3,(H,39,42)(H,40,41)/t28-,36-/m0/s1
InChIKeyGTRDYIJWUWRGOM-GOOPYHEFSA-N
XLogP6.85
TPSA136.67 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds3
Heavy Atoms49
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500674.75
LogP ≤ 56.85
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze GTRDYIJWUWRGOM-GOOPYHEFSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of GTRDYIJWUWRGOM-GOOPYHEFSA-N?
The IUPAC name of GTRDYIJWUWRGOM-GOOPYHEFSA-N (CID 129068123) is tert-butyl (2S)-4,4-difluoro-2-[6-[2-[4-[2-[(2S)-2-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]ethynyl]-1H-benzimidazol-2-yl]pyrrolidine-1-carboxylate.
What is the SMILES notation for GTRDYIJWUWRGOM-GOOPYHEFSA-N?
The canonical SMILES for GTRDYIJWUWRGOM-GOOPYHEFSA-N is CC(C)(C)OC(=O)N1CC(F)(F)C[C@H]1c1nc2ccc(C#Cc3ccc(-c4cnc([C@@]5(O)CCCN5C(=O)OC(C)(C)C)[nH]4)cc3)cc2[nH]1.
What is the InChIKey of GTRDYIJWUWRGOM-GOOPYHEFSA-N?
The InChIKey is GTRDYIJWUWRGOM-GOOPYHEFSA-N. The full InChI is InChI=1S/C36H40F2N6O5/c1-33(2,3)48-31(45)43-21-35(37,38)19-28(43)29-40-25-15-12-23(18-26(25)41-29)9-8-22-10-13-24(14-11-22)27-20-39-30(42-27)36(47)16-7-17-44(36)32(46)49-34(4,5)6/h10-15,18,20,28,47H,7,16-17,19,21H2,1-6H3,(H,39,42)(H,40,41)/t28-,36-/m0/s1.
What are the key properties of GTRDYIJWUWRGOM-GOOPYHEFSA-N?
GTRDYIJWUWRGOM-GOOPYHEFSA-N has a molecular weight of 674.75 g/mol, XLogP of 6.85, 3 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for GTRDYIJWUWRGOM-GOOPYHEFSA-N is sourced from PubChem (CID 129068123), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.